Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1499, 2005-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ambrisentan: ARIES results are a good sign for PAH
Inpharma, Vol. 1, Iss. 1593, 2007-01 ,pp. :
Access to resources
Recommend
American Journal of Cardiovascular Drugs, Vol. 11, Iss. 4, 2011-08 ,pp. :
By Croxtall Jamie D. Keam Susan J.
Drugs, Vol. 68, Iss. 15, 2008-01 ,pp. :
May Exercise Prevent Addiction?
Current Neuropharmacology, Vol. 9, Iss. 1, 2011-03 ,pp. :
Dasatinib [Sprycel] may increase the risk of pulmonary arterial hypertension (PAH)
Reactions Weekly, Vol. 1, Iss. 1374, 2011-01 ,pp. :